Related Experiment Video
Updated: Oct 28, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Comparison of Iron Profile in Patients With and Without Coronary Heart Disease
Zain Amar1, Abdul Subhan Talpur2, Shumaila Zafar3
1Internal Medicine, Isra University, Hyderabad, PAK.
Insights
Elevated serum ferritin levels are strongly associated with coronary artery disease (CAD). Managing high ferritin may reduce the risk of developing CAD.
Area of Science:
- Cardiology
- Biochemistry
- Internal Medicine
Background:
- Atherosclerosis, a primary cause of coronary artery disease (CAD), involves low-density lipoprotein (LDL) oxidation within macrophages.
- Ferritin and iron possess pro-oxidant properties, with ferritin independently predicting oxidized LDL levels.
Purpose of the Study:
- To investigate the association between serum ferritin and iron levels and the prevalence of coronary artery disease (CAD).
Main Methods:
- A case-control study involving 400 CAD patients and 400 controls was conducted.
- Serum ferritin, serum iron, and total iron-binding capacity (TIBC) were measured and compared between groups.
Main Results:
- Patients with CAD exhibited significantly higher serum ferritin levels (921.21 ± 201.21 ug/L) compared to controls (101.21 ± 92.21 ug/L; p<0.0001).
- Serum TIBC was significantly lower in the CAD group (302.12 ± 101.75 umol/L) versus the control group (362.12 ± 82.16 umol/L).
Conclusions:
- Higher ferritin levels indicate an increased risk for CAD.
- Consulting a physician for ferritin level management, potentially through lifestyle changes or medication, is recommended to mitigate CAD risk.
Abstract:
Introduction Atherosclerosis is considered a major cause of coronary artery disease (CAD). Pathogenesis of atherosclerosis involves the oxidation of low-density lipoprotein (LDL) within the lysosomes of macrophages. Ferritin and iron have pro-oxidant properties, and ferritin is an independent positive determinant of oxidized LDL level. In this study, we will determine the association between ferritin and serum iron levels and CAD. Methods This case-control study was conducted in the cardiology unit of a tertiary care hospital in Pakistan from December 2020 to April 2021. After taking informed consent, 400 patients with a confirmed diagnosis of CAD were enrolled. Another set of 400 patients without a history of CAD were included in the control group. A blood sample of 5 ml was drawn and sent to the laboratory to test for ferritin, serum iron, and total iron-binding capacity (TIBC). Ferritin, serum iron, and iron-binding capacity were compared between the case and control groups. Results Serum ferritin was significantly higher in patients with CAD compared to patients without CAD (921.21 ± 201.21 ug/L vs. 101.21 ± 92.21 ug/L; p-value: <0.0001). Serum TIBC was significantly lower in patients with CAD compared to patients without CAD (302.12 ± 101.75 umol/L vs. 362.12 ± 82.16 umol/L). Conclusion Patients with raised levels of ferritin should consult a physician to manage their ferritin levels since they are at a greater risk of CAD. Treatment ranges from lifestyle changes to pharmacological therapy, thus reducing the overall risk and normalizing the ferritin levels.
More Related Videos
05:08Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease IV: Preventive Measures